Notice of Change to Funding Opportunity: RFA-FD-24-029 Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional
Notice Number:
NOT-FD-24-004

Key Dates

Release Date:

February 6, 2024

Related Announcements

  • December 28, 2023 - Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional. See NOFO RFA-FD-24-029.

Issued by

FOOD AND DRUG ADMINISTRATION (FDA)

Purpose

The purpose of this Notice is to update the “Award Budget” details in the "Section II. Award Information" section of this NOFO and to remove the verbiage under the section titled, "7. Other Submission Requirements and Information" pertaining to "Requests of $500,000 or more for direct costs in any year."  For clarity, the previous paragraph pertaining to “Requests of $500,000 or more for direct costs in any year” is not applicable to this NOFO.

Currently reads:

Application budgets should reflect the needs of the proposed program annually, including the initiatives indicated at the initial award and those proposed post-award. These should not exceed the listed amounts in total costs (direct and indirect):

YR 01: $5,000,000

YR 02: $5,000,000

YR 03: $5,000,000

YR 04: $5,000,000

YR 05: $5,000,000 

Modified to read:

Application budgets should reflect the needs of the proposed program annually. These should not exceed the listed amounts in total costs (direct and indirect):

YR 01: $5,000,000

YR 02: $5,000,000

YR 03: $5,000,000

YR 04: $5,000,000

YR 05: $5,000,000 

Currently reads: 

Requests of $500,000 or more for direct costs in any year

Applicants requesting $500,000 or more in direct costs in any year (excluding consortium F&A) must contact a Scientific/ Research Contact at least 6 weeks before submitting the application and follow the Policy on the Acceptance for Review of Unsolicited Applications that Request $500,000 or More in Direct Costs as described in the SF424 (R&R) Application Guide.

Modified to read: (NIH please remove this verbiage/paragraph altogether)

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Terrin Brown
Office of Acquisitions & Grants Services (OAGS)
Food and Drug Administration
Email: Terrin.Brown@fda.hhs.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices